ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. The services offered to clients include antibody discovery against a broad spectrum of antigens through hybridoma production, B-cell services, and a variety of phage display platforms.